<DOC>
	<DOCNO>NCT01516528</DOCNO>
	<brief_summary>This prospective , observational , non-drug interventional , non-randomized study compare rate moderate-severe COPD exacerbation patient Chronic Obstructive Pulmonary Disease ( COPD ) severities without cardiovascular disease . A total study population 3330 subject recruit general practitioner ( GPs ) assess 27 month time frame .</brief_summary>
	<brief_title>Assessment Comorbidities Chronic Obstructive Pulmonary Disease ( COPD ) European Symptomatic Subjects From Primary Care</brief_title>
	<detailed_description>COPD lead cause morbidity mortality worldwide . Comorbid diseases important factor prognosis functional capability COPD patient . There relationship cardiac comorbidity COPD exacerbation frequency within COPD patient . The main objective study compare rate moderate-severe COPD exacerbation patient COPD severity without cardiovascular disease . Secondary objective characterize prevalence , severity incidence time comorbidities explore relationship comorbidities rate COPD exacerbation , force expiratory volume 1 second ( FEV1 ) decline quality life . This prospective , observational , non-drug interventional , non-randomized study carry 8 European country . All patient enrol GP outpatient clinic data collect 4 visit ( screen [ -3 month ] , baseline , 12 month post baseline 24 month post baseline ) , additionally 6 telephone call ( 3 , 6 , 9 , 15 , 18 21 month post baseline ) . The study population consist 3330 evaluable patient diagnose COPD severity grade without comorbidities . Subjective objective data pre-defined comorbidities collect analyzed .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Male female patient age ≥ 40 year An established clinical history COPD minimum 12 month , severity . FEV1/FVC postbronchodilator ratio &lt; 0.70 ( within last 12 month , confirm screen visit [ 4 week screen visit patient 's COPD stable ] ) . Current exsmokers smoke history least 10 packyears A sign date write informed consent obtain prior participation In opinion investigator , current primary diagnosis asthma ( patient primary diagnosis COPD also asthma may include ) A diagnosis fibrosis asbestosis Diagnosis cancer current within last 5 year ( patient remission ≥ 5 year may include ) . Patients diagnose cancer study withdraw Diagnosis clinically significant bronchiectasis Subjects concurrently participate clinical study receive investigational drug within 4 week baseline , start study period . Unable unwilling conform study requirement include completion health status questionnaires Females pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>COPD</keyword>
	<keyword>exacerbation</keyword>
	<keyword>comorbidities</keyword>
	<keyword>lung function</keyword>
	<keyword>burden</keyword>
	<keyword>chronic bronchitis</keyword>
	<keyword>emphysema</keyword>
	<keyword>prevalence</keyword>
	<keyword>cardiovascular disease</keyword>
</DOC>